The Institute of Psychiatry, Psychology and Neuroscience at King's College London have shown that many of the symptoms in fibromyalgia syndrome are caused by antibodies that increase the activity of pain-sensing nerves throughout the body.
Fibromyalgia affects at least 1 in 40 people, where 80% of those are female. Symptoms typically include flare-ups of wide spread pain throughout the body, as well as fatigue, disturbed sleep and emotional distress. This condition can have detrimental effects to quality of life. It commonly develops between the ages of 25-55, although children can also get it.
This new research may completely revolutionise the way in which those with fibromyalgia are managed, and now treated. Now it is known that antibodies play a crucial role in the condition, it offers hope to the millions that suffer with fibromyalgia that an effective treatment could be found in the not so distant future.
Goebel et al., (2021). Passive transfer of fibromyalgia symptoms from patients to mice. The Journal of Clinical Investigation.